A nonviral gene delivery vector has been developed in our laboratory based on the cationic polymer, poly( 2 -( dimethylethylamino )ethyl methacrylate ) ( p( DMAEMA ) ). p( DMAEMA ) -based polyplexes have been successfully used for the transfection of OVCAR -3 cells in vitro. However, these polyplexes were unable to transfect OVCAR -3 cells growing in the peritoneal cavity of nude mice after intraperitoneal administration, which could be ascribed to inactivation by components ( including hyaluronic acid ) present in the tumor ascitic fluid. The present work aimed at ( a ) protecting p( DMAEMA ) -based polyplexes against destabilization or inactivation by polyanions such as hyaluronic acid present in tumor ascitic fluid and ( b ) enhancing cellular uptake of the protected p( DMAEMA ) -based polyplexes by targeting with antibody Fab H fragments. To fulfill these requirements, we have developed a detergent removal method to coat polyplexes with anionic lipids. With this method, spherical particles of $125 nm, which were protected from destabilization by polyanions, were obtained. More importantly, the transfection efficiency of lipopolyplexes was unaffected in the presence of hyaluronic acid, indicating that lipid coating of polyplexes protects against destabilization by hyaluronic acid. By conjugating antibody Fab H fragments directed against the epithelial glycoprotein -2 to the lipidic surface of these lipopolyplexes, target cell ± specific transfection of OVCAR -3 cells could be obtained in vitro. Cancer Gene Therapy ( 2001 ) 8, 405 ± 413
O varian cancer is one of the most common and fatal human gynecological malignancies. As ovarian cancer remains confined to the peritoneal cavity throughout most of its clinical course, this type of cancer is an attractive candidate for intraperitoneal ( i.p. ) cancer gene therapy. 1, 2 Naked DNA does not easily pass cell membranes. Therefore, a carrier that can deliver genes into cells is needed. Viral vectors have been successfully utilized for the delivery of genetic material as they contain all features necessary for efficient gene transfer (i.e., cell adhesion, membrane translocation, efficient transcription, and translation ). 3, 4 However, despite efficient gene transfer, viral vectors have some limitations, in particular their relatively small packaging capacity of therapeutic DNA, safety concerns, and immunogenicity. 5, 6 In addition, the broad tropism of viruses used for gene delivery prevents cell -specific gene delivery. These limitations of viral vectors have led to the development and evaluation of alternative gene carriers based on synthetic, nonviral components. 5, 7 Most nonviral vectors to date are based on the complexation of plasmid DNA with polycations by electrostatic interaction. The advantage of this method is that relatively small and positively charged particles, which can be taken up by cells, can be obtained. Moreover, complexation of DNA with polycations such as cationic peptides, polymers (polyplexes ), or lipids (lipoplexes ) protects, to a large extent, the DNA from degradation by nucleases.
In our laboratory, a nonviral gene delivery vector has been developed based on the cationic polymer, poly( 2 -( dimethylethylamino) ethyl methacrylate ) (p( DMAEMA )), that forms stable and small ( $100 nm ) particles upon complexation with plasmid DNA. 8 ± 10 These cationic polyplexes have been used successfully to introduce reporter genes into ovarian carcinoma (OVCAR -3) cells cultured in vitro. The p( DMAEMA )-based polyplexes were subsequently used in vivo for the transfection of OVCAR -3 cells growing in the peritoneal cavity of nude mice. 11 The results of the in vivo transfection experiments were disappointing: p( DMAEMA ) -based polyplexes showed negligible transfection of intraperitoneally localized OVCAR -3 cells after i.p. administration. It has been reported that interaction of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans has an inhibitory effect on gene transfer. 12 Indeed, with our polyplexes, evidence was obtained that one or more components present in the peritoneal ascitic fluid (among which was hyaluronic acid ) induced a detrimental effect on the in vivo transfection capability of p( DMAEMA )-based polyplexes. Clearly, in order to obtain effective gene transfer of ovarian carcinoma cells under in vivo conditions, polyplexes need to be protected from the inactivating effects of tumor ascitic components.
In this study, we aimed at protecting p( DMAEMA )-based polyplexes against inactivation induced by components such as hyaluronic acid, which are present in tumor ascitic fluid. In addition to protection, we also aimed at enhancing the transfection efficiency of protected polyplexes by conjugating targeting ligands to the transfection system to facilitate the uptake of protected polyplexes by ovarian carcinoma cells. For the protection of p( DMAEMA )-based polyplexes against inactivation, we have developed a detergent removal method to coat the cationic polyplexes with anionic lipids. This method is based on the preferential formation of a lipid coat around the positively charged polyplexes upon transition of phospholipids from mixed micellar to lamellar state induced by slow removal of the detergent. Lipid coating of polyplexes should fulfill several functions. First, the coating should shield the positive surface charge of polyplexes that may cause aggregation of polyplexes upon exposure to the biological environment. Second, it should protect the polyplexes from interaction with inactivating substances such as hyaluronic acid. Third, as it is expected that shielding of positive surface charges prevents the aspecific binding to cells, 13 tumor-specific antibodies or antibody fragments can be conjugated to the lipid coating to obtain specific cellular uptake. Here, we show that the intended protection and targeting effects can be realized for p( DMAEMA )-based polyplexes using the proposed lipid coating and antibody coupling procedures.
MATERIALS AND METHODS

Chemicals
Egg phosphatidylglycerol (EPG ) and egg phosphatidylcholine ( EPC ) were purchased from Avanti Polar Lipids ( Alabaster, AL ). Cholesterol (CHOL ), n-octyl --D -glucopyranoside ( OG ), o -nitrophenyl --D -galactopyranoside ( ONPG ), poly( aspartic acid ) (p( Asp )), hyaluronic acid, DNase (grade I), and sodium 3 H -[ 1-(phenylaminocarbonyl )-3,4 -tetrazolium ]-bis( 4 -methoxy -6 -nitro )benzene sulfonic acid hydrate (XTT ) were obtained from Sigma ( St. Louis, MA ). N-[4-(p-Maleimidophenyl )butyryl ]phosphatidylethanol -amine (MPB -PE ) was synthesized as described before.
14 BioBeads SM -2 nonpolar polystyrene adsorbents came from Bio -Rad Laboratories ( Hercules, CA ). The PicoGreen DNA detection kit was obtained from Molecular Probes (Eugene, OR ). All other reagents were of analytical grade.
Plasmid DNA
The plasmid pCMVLacZ containing a bacterial LacZ gene preceded by a nuclear localization signal under control of a CMV promoter was kindly donated by Dr. A. Bout ( IntroGene, Rijswijk, the Netherlands ). 15 The plasmid was amplified in Escherichia coli (strain DH5 ) and purified by column chromatography using a purification method that fully removes endotoxins (Qiagen Endofree Kit; Qiagen, Leusden, the Netherlands ). The plasmid DNA was shown to be absent of RNA or bacterial DNA as analyzed by gel electrophoresis and absent of endotoxins as determined by the limulus amoebocyte lysate assay. Purity of the plasmid was determined by UV spectroscopy giving a A 260 /A 280 ratio of 1.84. Furthermore, gel electrophoresis and anion exchange chromatography showed that the plasmid DNA was in the supercoiled and open circular form in a ratio of about 1:1. 16 
Cell culture
The human ovarian carcinoma cell line, NIH:OVCAR -3, originated from the laboratory of Dr. Hamilton (National Cancer Institute, Bethesda, MD ). 17 OVCAR -3 cells were cultured in Dulbecco's modified Eagle's medium containing 3.7 g/ L sodium bicarbonate, 4.5 g/ L L -glucose and supplemented with L -glutamine (2 mM ), HEPES ( 10 mM ), 10% (vol / vol ) fetal calf serum (FCS ), penicillin ( 100 iu /mL ), streptomycin (100 g /mL ), and amphotericin B ( 0.25 g /mL ).
Polyplex formation and characterization
For condensation of the pCMVLacZ plasmid DNA, the polymer p( DMAEMA ) synthesized at our laboratory was used. 8 The weight average molecular weight (M w ) and number average molecular weight ( M n ) of p( DMAEMA ) were determined by gel permeation chromatography. The used batch of p( DMAEMA ) had a M w of 2.1Â10 6 and a M n of 4.1Â10 4 . Stock solutions of p( DMAEMA ) at a concentration of 37.5 g/ mL were prepared in HEPES buffer ( 5 mM HEPES, pH 7.4 ). Two and a half micrograms of pCMVLacZ plasmid DNA at a final concentration of 10 g /mL in HEPES buffer ( 5 mM HEPES, pH 7.4) was condensed by adding the p( DMAEMA ) at a 3:1 ( wt /wt ) ratio to the DNA, followed by vigorously shaking for 5 seconds on a vortex. This ratio was chosen as at this ratio, small -sized particles were obtained without the presence of free polymer. 18 After 30 minutes of maturation at room temperature, the formed polyplexes were analyzed for size distribution by dynamic light scattering and -potential as previously described. 8 The polyplexes had a mean diameter of approximately 80 nm with a -potential of + 25 ±30 mV ( in 5 mM HEPES, pH 7.4).
Lipid solubilization with OG: turbidity assay
Lipid films ( 3 mol of total lipid ) of different compositions were prepared from lipid stocks in a mixture of chloroform / methanol ( 2:1 ) by solvent evaporation under low pressure using a rotavapor device. A series of lipid films was hydrated in 1 mL of HEPES buffer ( 5 mM HEPES, pH 7.0 ) at increasing concentrations of OG ( 0± 30 mM ) for 30 minutes at room temperature under gentle agitation. Hereafter, the turbidity of all solutions was measured (OD 400 ) spectrophotometrically. As liposomes have a much higher turbidity than mixed micelles, 19 turbidity determination can be used to assess the minimum OG concentration required to achieve complete lipid solubilization into mixed micelles. The stability of polyplexes in the presence of OG detergent at a concentration just high enough to completely solubilize Cancer Gene Therapy, Vol 8, No 6, 2001 the lipids was evaluated by monitoring the change in particle size in time with dynamic light scattering. The size of polyplexes was measured every 15 minutes for 2 hours. Polyplexes were considered to be stable if particle size did not increase by more than 10% after 2 hours of incubation in the presence of detergent.
Preparation of lipopolyplexes ( LPPs ) and immunolipopolyplexes ( ILPPs )
Lipid films containing 3 mol of total lipid (EPC:EPG:-CHOL molar ratio 2:2:1, unless mentioned otherwise) were formed from lipid stocks in a mixture of chloroform / methanol (2:1 ) by solvent evaporation under low pressure using a rotavapor device. The lipid films were further dried under a stream of nitrogen for 1 hour. Lipid films were solubilized by adding 1 mL of 18 mM OG in HEPES buffer ( 5 mM HEPES, pH 7.0 ). Subsequently, p( DMAEMA )-based polyplexes prepared as described above ( see Polyplex Formation and Characterization ) were added to the solubilized lipid films in an amount corresponding with 2.5 g of plasmid DNA. Twenty -five micrograms of BioBeads was added and the polyplex /lipid micelle mixtures were shaken for 1 hour at 1400 rpm using a IKA MTS2 shaker. Hereafter, 200 mg of BioBeads was added and again the samples were shaken for 1 hour, then samples were separated from the BioBeads and final traces of detergent were removed by overnight dialysis at 48C against 1 liter of HEPES-buffered salt solution ( 5 mM HEPES, 150 mM NaCl, pH 7.4).
For coupling antibody Fab H fragments to the lipid surface of LPP, 2.5 mol% (of total lipid ) of MPB -PE was added to the lipids before solvent evaporation. MPB -PE is an anchor molecule commonly used to couple antibodies or enzymes to liposomes and is thiol-reactive. 14, 20 Three micrograms of ( Fab) 2 fragments of mAb 323/ A3 was reduced with 20 mM DTT in a total volume of 1 mL of 100 mM NaCl, 35 mM sodium phosphate, 20 mM citric acid, and 1 mM EDTA, pH 5.5, for 90 minutes at room temperature under nitrogen atmosphere. Reduced Fab H fragments containing free thiol groups were separated from DTT by column chromatography using a PD -10 column (Pharmacia Biotech, Uppsala, Sweden ) equilibrated with deoxygenated PIPES buffer ( 20 mM PIPES, 140 mM NaCl, pH 6.5) and added to freshly prepared LPP containing the MPB -PE functionalized phospholipid in a Slide -A -Lyzer dialysis slide ( MWCO 10,000; Pierce, Rockford, IL ). The coupling reaction was proceeded overnight at 48C whereas dialysis against 0.8 liter of PIPES buffer ( 20 mM PIPES, 140 mM NaCl, pH 6.5) was continued. The formed ILPP particles were separated from unconjugated Fab H fragments by ultracentrifugation (40 minutes at 60,000 rpm ).
LPP and ILPP were characterized for phospholipid and protein amount, size distribution, and surface charge. Phospholipid amount was determined by the colorimetric method of Fiske and Subbarow. 21 The contribution of DNA to the total phosphate amount of LPP particles was negligible as determined with phosphate determination after phospholipid extraction according to Bligh and Dyer. 22 The amount of conjugated Fab H on the surface of the ILPP was determined with the Bio-Rad DC protein assay kit ( BioRad Laboratories ) with mouse IgG as standard (obtained from Sigma). Size distribution and surface charge properties of LPP and ILPP were determined by DLS and -potential measurements, respectively.
Electron microscopy
Polyplexes and LPP were adsorbed to glow -discharged carbon -stabilized formvar-coated grids, negatively stained using 2.0% potassium phosphotungstate (pH 5.2 ) and analyzed in a Philips TEM 400 electron microscope ( Eindhoven, The Netherlands ) at an operating voltage of 80 kV. Images were digitally stored and analyzed using analySIS ( Soft Imaging Software, Mu Ènster, Germany ). Images were printed after grey value modification.
Nuclease resistance assay
Freshly prepared LPP and a mixture of polyplexes and empty anionic liposomes were exposed to a large excess of p( Asp ) ( 1 mg /mL final concentration in HEPES buffer, pH 7.0 ) to liberate DNA from polyplexes. 9, 23 Subsequently, 1/ 10 vol of 10Â DNase I reaction buffer (1 M sodium acetate, 50 mM MgCl 2 ) and 4 U of DNase I were added and samples were incubated for 3 hours at 378C. Hereafter, DNase I was inactivated by adding EDTA (40 mM final concentration ), and lipid vesicles ( LPP or empty liposomes) were disrupted by the addition of OG ( 50 mM final concentration ). An additional amount of p( Asp ) was added before analyzing the samples by gel electrophoresis on a 0.7% agarose gel containing 0.5 g /mL ethidium bromide, in TAE buffer (pH 7.4 ).
Quantitative determination of plasmid DNA in LPP p( Asp ) is able to dissociate polyplexes, but not LPP, as they possess a protective lipid coat. This feature of p(Asp ) is utilized to determine indirectly the amount of DNA present in LPP. The LPP dispersion was incubated for 3.5 hours at 408C either with p( Asp ) (1 mg / mL ) to liberate the DNA from polyplexes present in the LPP dispersion or with p( Asp ) ( 1 mg / mL ) and 1% (vol / vol ) Triton X -100 to liberate DNA from LPP. Triton X -100 disrupts the lipid coat of LPP, allowing p( Asp ) to liberate the DNA from polyplexes inside LPP. The amount of liberated DNA was quantified with the PicoGreen dsDNA detection kit (Molecular Probes ) according to the manufacturer's protocol. PicoGreen fluorescence was measured with a LS50B fluorometer (Perkin Elmer, Beaconsfield, Bucks, UK ), set at an excitation wavelength of 480 nm and an emission wavelength of 520 nm. By subtracting the amount of non-LPP associated DNA determined by incubation with p( Asp ) from the total amount of DNA determined by incubation with p( Asp ) and Triton X -100, the amount of DNA inside LPP could be derived.
Transfection studies
Cells were plated in 96-well plates at 1.1Â10 4 cells/well and cultured for 24 hours prior to transfection, by which time the adherent cells were $60 ±80% confluent. Cells were over-
laid with 100 L of prewarmed culture medium containing 10% FCS before the addition of polyplexes, LPP, or ILPP particles (corresponding to 1 g of DNA ) in triplicates. From here, three different methods were followed: In thè`s hort-term exposure'' method cells were exposed to the DNA particles for 1 hour at 378C after which the transfection medium containing the DNA particles was replaced by fresh culture medium containing 10% FCS and incubation was continued for another 47 hours. In the``prolonged exposure'' method, DNA particles were not removed from the cells, but cells remained exposed for the total 48 -hour incubation time. The third method is the same as the``short-term exposure'' method with the difference that hyaluronic acid ( 2.5 mg /mL ) is additionally present in the wells during DNA particle exposure. This concentration is sufficient to block the transfection capability of p( DMAEMA )-based polyplexes.
11 Cells were evaluated for -galactosidase expression and viability using a slightly modified ONPG assay and the XTT assay, essentially as described before. 9 
RESULTS
Size stability of p( DMAEMA ) -based polyplexes in the presence of detergent
In this study, a procedure was developed to coat small -sized, cationic polyplexes with lipids using a detergent removal method ( Fig 1) . Initially, lipid -coated polyplexes (further referred to as LPP ) were formed by adding p( DMAEMA )-based polyplexes ( 3:1 wt /wt ratio of polymer:DNA ) to 3 mol of lipids solubilized in 150 mM OG and subsequent slow removal of the detergent by adsorption to hydrophobic polystyrene BioBeads. The used OG concentration is far above the critical micelle concentration ( 14.5 mM according to manufacturer ) and it turned out that this high concentration of detergent had a negative influence on the stability of the formed polyplexes as a substantial increase in size of polyplexes occurred in time (results not shown ). Therefore, in an attempt to avoid this problem, the minimal concentration of OG necessary to completely solubilize the lipids was determined and size stability of polyplexes at this concentration was monitored.
Lipid films (3 mol of total lipid ) of different compositions were prepared: EPG:EPC:CHOL at the molar ratios of 2:2:1 (40% EPG ), 1:7:2 (10% EPG ), and 0:4:1 (0% EPG ).
For each composition, lipids were hydrated at increasing concentrations of OG. Figure 2 shows that the amount of PG included in the lipid film influences the solubilization capacity of OG for the lipids. At decreasing amounts of PG in the lipid film, increasing concentrations of OG are needed in order to totally solubilize the lipids into mixed micelles. Table 1 shows that, at the different amounts of PG tested, polyplexes do not change in size within the OG concentration range of 18 ± 32 mM (stable for at least 2 hours ). Thus, low OG concentrations can be used to solubilize anionic lipid compositions into mixed micelles with preservation of the size stability of the polyplexes.
Effect of lipid / polyplex ratio on the size of LPP
The influence of the total amount of lipid on the size of formed LPP was determined. LPPs were prepared at a fixed polyplex concentration ( corresponding to 2 g /mL DNA and 6 g /mL p( DMAEMA )) and increasing concentrations of OG -solubilized lipids (0 ±4 mol /mL TL; PC:PG:CHOL molar ratio 2:2:1). After slow removal of the detergent by adsorption to BioBeads and exhaustive dialysis against HEPES -buffered salt solution, the mean size of the LPP was determined ( Fig 3) . It can be seen that the apparent mean size of LPP varied with the lipid/polyplex ratio. At lipid amounts > 1 mol TL, small LPPs were obtained with an average size of $100 ± 200 nm. LPPs prepared at lipid amounts < 1 mol TL showed larger particle sizes. In the experiments described below, LPPs prepared at 3 mol of lipids were used.
Characterization of LPP
LPPs prepared with the detergent removal method were characterized for mean particle size, -potential, and morphology. At 3 mol of TL, the formed LPP had an average size of 125 nm and a -potential between À 50 and À 60 mV. Both parameters did not change during storage at 48C for at least 2 weeks. The morphology of LPP was compared with that of polyplexes by negative stain electron microscopy. As shown in Figure 4A , polyplexes are small, spherical particles with an average diameter of 80 9 nm. Most of these particles are roundish of shape. Due to the negative staining technique, they show a mark halo of stain and appear as moderately electron dense as they attract much of the negative stain onto their positive charged surface. In contrast, LPPs appear as electron light particles in a background of stain. Due to their negative surface charge, there is a general failure of PTA to penetrate into these particles resulting in the presence of a white halo ( Fig 4B ) . Besides small particles with a size variable from 50 to 70 nm ( most likely empty liposomes), also larger (100 ± 150 nm ) polymorphic structures can be observed, which consist of condensed structures surrounded by a lipid coat (LPP; marked with arrows in Figure 4B ). The presence of these polymorph structures probably accounts for the large size distribution range of LPP as indicated by the polydispersity index of 0.3 ± 0.4.
LPPs are protected against polyanion destabilization
Previous work from our group has demonstrated that p( DMAEMA )-based polyplexes are destabilized when exposed to p( Asp ), which liberates the DNA from the polyplexes and making it susceptible to DNase I± induced degradation. 9 Here, we investigated whether polyplexes present in LPPs are protected against destabilization with p( Asp ). LPP and polyplexes admixed with empty anionic liposomes were incubated with DNase I in the presence of a large excess of p( Asp ). Before and after the addition of DNase I, samples were analyzed by gel electrophoresis for the presence of nondegraded plasmid DNA (Fig 5 ) . It is demonstrated that there is no difference in DNA staining intensity between LPP before (lane 2 ) and after (lane 1 ) treatment with DNase I, indicating that a large amount ( if not all ) of the polyplexes within LPP is protected from destabilization with p( Asp ). In contrast, polyplexes that were admixed with empty preformed liposomes with the same lipid composition as in the LPP coat appeared very sensitive to destabilization with p( Asp ), as DNase I completely degraded complexed DNA (lanes 3 and 4 ) . These results indicate that coating of polyplexes with lipids protects the polyplexes from destabilization by p( Asp ).
Quantitative determination of DNA in LPP
To quantify the efficiency of the lipid coating procedure, the amount of polyplexes effectively coated with lipids ( LPP ) was determined with an assay, which is based on the 
Effect of lipid/polyplex ratio on the size of LPP-particles
Mean particle size (nm) Figure 3 . Effect of lipid / polyplex ratio on the size of LPP. LPPs were prepared at a fixed amount of polyplexes ( corresponding to 2.5 g of DNA ) with increasing amounts of lipids. Mean size was determined by dynamic light scattering. observation (see LPPs are Protected Against Polyanion Destabilization) that polyplexes in LPP are protected from dissociation in the presence of a large excess of p( Asp ). Figure 6 shows that the degree of protection conferred by the lipid coating is positively correlated with the amount of negatively charged PG used for the coating. Complete protection of polyplexes was obtained when the lipid coat of LPP contained 40 mol% PG, 70% protection was obtained when the coat contained 10 mol% PG, and 50% protection when the coat lacked negatively charged PG. These results suggest that electrostatic interactions between the cationic polyplexes and negatively charged phospholipids promote the coating of polyplexes with lipids occurring during the slow removal of detergent from the detergent -solubilized lipids.
Conjugation of Fab
H fragments to LPP ( ILPP )
As our aim is to target genes to ovarian carcinoma cells, we have conjugated Fab H fragments of mAb 323/ A3 to the surface of LPP. This mAb binds specifically to the epithelial glycoprotein -2 (EGP -2, EPCAM ), which is expressed at high levels on the surface of OVCAR -3 cells. 24, 25 After conjugation, the amount of Fab H molecules coupled to the surface of LPP was determined. These antibody -targeted LPPs (further referred to as ILPP ) contained an average of 20± 30 conjugated Fab H molecules for each vesicle.
Comparative transfection capability of polyplexes, LPP, and ILPP
The capability of polyplexes, LPP, and ILPP (both LPP and ILPP both contained 40 mol% PG ) to transfect 
COS-7
Relative Transfection P o l y p l e x e s L P P I L P P Figure 7 . Transfection of OVCAR -3 cells ( EGP -2 + ) and COS -7 cells ( EGP -2 À ) after short -term ( 1 hour ) exposure to polyplexes, LPP or ILPP. Cells ( 1.1Â10 4 cells / well ) were exposed for 1 hour at 378C to either polyplexes, LPP, or ILPP ( at 1 g of plasmid DNA ). Gene carriers were removed by washing and cell culture was continued for another 47 hours prior to evaluation of -galactosidase expression. cultured OVCAR -3 cells was investigated under three different transfection conditions. Cells were exposed to the DNA formulations for ( a) 1 hour, ( b) 48 hours, and ( c) 1 hour in the presence of hyaluronic acid ( 2.5 mg / mL ). Hyaluronic acid was used as this component has been shown to have an adverse effect on the transfection capability of plain polyplexes ( see LPPs are Protected Against Polyanion Destabilization and van de Wetering et al. 11 ). However, it is hypothesized that hyaluronic acid will not adversely affect the transfection capability of LPP and ILPP due to the protective lipid layer. Figure 7 shows the transfection results obtained when cells were exposed for 1 hour to the different DNA formulations. It is clear that both negatively charged LPP and ILPP are much less efficient in transfecting OVCAR -3 cells compared to positively charged polyplexes under the tested conditions. Nevertheless, the antibody -targeted ILPP are 10 -fold more efficient than LPP in transfecting OVCAR -3 cells. In addition, the efficiency of ILPP to transfect COS -7 cells (lacking EGP -2 expression ) is not enhanced compared to nontargeted LPP, indicating that antibody -mediated targeting to OVCAR -3 cells can be achieved. No cytotoxicity was observed with all DNA formulations used ( polyplexes, LPP, and ILPP ) in the shortterm exposure setting ( results not shown). Figure 8 shows the results of transfection of OVCAR -3 cells after long -term exposure ( =48 hours ) to polyplexes, LPP, or ILPP. It can be seen that long -term exposure of cells to the polyplexes was detrimental for the transfection efficiency of this transfection system (compare with effect in Figure 7 ). The reason for this negative effect lies in increased cytotoxicity: the cell viability was only about 5%. Cytotoxicity was not observed when cells are exposed for 48 hours to LPP and ILPP. In this long -term exposure setting, the transfection efficiency of ILPP was about 2.5 times higher than that of plain polyplexes. LPP hardly gave any transfection in contrast to the ILPP, indicating that antibodymediated binding of the LPP to OVCAR -3 cells is critical for achieving transfection of OVCAR -3 cells.
As we have shown (see LPPs are Protected Against Polyanion Destabilization) that coating of polyplexes with lipids protects the polyplexes from polyanion -induced destabilization, we have compared transfection results obtained with polyplexes and ILPP in the absence and presence of the polyanion hyaluronic acid, which is abundantly present in tumor ascitic fluid (Fig 9) . Whereas the transfection efficiency of polyplexes is drastically reduced in the presence of hyaluronic acid (Fig 9A ) , this reduction is not observed with ILPP ( Fig 9B ) , indicating that hyaluronic acid does not negatively affect the transfection efficiency of ILPP.
DISCUSSION
Local delivery of therapeutic genes into ovarian carcinoma cells is an attractive strategy for the treatment of ovarian carcinoma. 1 As naked DNA is very unstable in the biological environment, is poorly taken up by target cells, and lacks cell specificity, a gene delivery carrier is needed to fulfill the requirements of stability and cellular uptake. For this purpose, the cationic polymer p( DMAEMA ) has been developed in our laboratory. p( DMAEMA ) can condense large-sized DNA into small and stable complexes of approximately 100 nm in size and which are protected from DNA degradation by DNase in vitro. 8, 9 Despite encouraging transfection results obtained with p( DMAEMA )-based polyplexes in vitro, in vivo transfection of ovarian carcinoma cells growing in the peritoneal cavity of nude mice is negligible.
11 Evidence exists that one of the components of the peritoneal ascitic fluid, hyaluronic acid, induced a detrimental effect on the in vivo transfection capability of p( DMAEMA ) -based polyplexes.
To address the problem of low in vivo transfection activity of p( DMAEMA )-based polyplexes, we present here a method of coating the p( DMAEMA ) -based cationic polyplexes with anionic lipids and show that the anionic lipid coating confers protection against destabilization of polyplexes by polyanionic molecules such as p( Asp ) and hyaluronic acid. However, the LPPs lack significant transfection capability likely due to the loss of cationic chargemediated electrostatic interaction with the cells. This problem can be overcome by coupling specific antibody fragments to the LPP surface, thus restoring cellular uptake and transfection. Both aspects, i.e., protection and targeting, will be discussed below.
The first requirement to meet was to create protection against polyanion -induced destabilization or inactivation. Previous transfection studies with plain p( DMAEMA )-based polyplexes have shown that hyaluronic acid, which is present at high levels in tumor ascitic fluid, has a dosedependent negative effect on the transfection efficiency of plain polyplexes ( see Figure 9A study, it is possible to coat polyplexes with lipids with efficiencies of up to 100% as reflected by complete protection against polyanion -induced destabilization. Moreover, this method yields stable particles with a small mean size ($120 nm ) and a net negative surface charge. The degree of protection conferred by the lipid coating is positively correlated with the amount of negatively charged lipids present in the coat, which indicates that electrostatic interactions promote the lipid coating process. Similarly, Lee and Huang 26, 27 took advantage of electrostatic interactions for coating polylysine -condensed DNA complexes with preformed anionic liposomes. Although analysis by negative stain electron microscopy revealed anionic lipid -coated particles, it was not shown whether the lipid coat really caused protection of the condensed DNA against degradation or destabilization. Here, we show that LPPs prepared with the detergent removal method are protected from destabilization by polyanions such as p(Asp ) and hyaluronic acid. In addition, the transfection efficiency of ILPP is not negatively influenced by the presence of high concentrations of hyaluronic acid, in contrast to the transfection efficiency of plain, unprotected polyplexes ( Fig 9 ) .
Unfortunately, besides the positive effect of conferring protection, the presence of a negatively charged lipid coat around LPP has a negative impact on cellular uptake of LPP. Cationic polyplexes are thought to electrostatically interact with cell membranes, thereby triggering cellular uptake mechanisms. 13 The observed lack of transfection capability and cytotoxicity of LPP is most likely due to absence of cellular association. Indeed, this is confirmed by our observation that targeting of LPP, which promotes specific cellular uptake of LPP, is a prerequisite to obtain transfection of ovarian carcinoma cells. Targeting of LPP to ovarian carcinoma cells (OVCAR -3) was realized by coupling Fab H fragments of mAb 323 /A3 (anti-EGP -2 ) to the surface of LPP ( ILPP ). However, despite the targeting effect, the transfection efficiency of ILPP is 20 -fold lower than that obtained with plain polyplexes in case of``short-term'' exposure (1 hour ) of cells to the gene carriers. This may well be explained by the quantitative difference in degree of cellular uptake between polyplexes and ILPP. The mechanism of nonspecific cellular uptake of plain polyplexes may be much more efficient than the mechanism of specific cellular uptake of ILPP (antibody -mediated binding and internalization ), the latter being dependent on antigendensity and kinetics of internalization of the target surface antigen EGP -2. The EGP -2 surface receptor is slowly internalized (50% after 48 hours ). 28 However, it should be realized that the 1-hour exposure period does, by far, not reflect the in vivo conditions in which peritoneal tumor cells are expected to be exposed to i.p. -injected ILPP for much longer periods of time. For this reason, we have compared the transfection levels of ovarian carcinoma cells after 48 hours of exposure to either plain polyplexes, LPP or ILPP. Under these``longterm exposure'' conditions, the transfection efficiency of the antibody -targeted ILPPs, which were 20 times less efficient in transfecting ovarian cancer cells under``shortterm exposure,'' is now 2.5 -fold more efficient in transfecting ovarian carcinoma cells compared to plain polyplexes. Moreover, even under``long -term exposure'' conditions, nontargeted LPP does not show any transfection, which illustrates the necessity of achieving target receptor ±mediated internalization. Apparently, the presence of the targeting ligand mediates cellular binding and uptake of the coated particles and compensates for the loss of electrostatic interaction with the cell membrane caused by the introduction of the lipid coating on the polyplex surface. It is noteworthy that in sharp contrast with the plain polyplexes, ILPP did not induce any cytotoxicity to the cells (Fig 8 ) . These findings indicate that antibodytargeted ILPPs are better suited for i.p. transfection of ovarian carcinoma cells than plain polyplexes.
CONCLUSION
The ILPP system introduced in this study features colloidal stability and transfection capability under conditions mimicking the in vivo situation and therefore shows promise for use in plasmid -based approaches to gene therapy of ovarian cancer. At present, the ILPP system is being investigated in our laboratory for its efficiency to deliver genes to ovarian carcinoma cells for the purpose of gene -dependent enzyme prodrug therapy. 29 
